Literature DB >> 727892

Morbidity suppressive effect of lithium carbonate in cycloid psychosis.

C Perris.   

Abstract

The possible morbidity suppressive effect of lithium carbonate on cycloid psychosis has been investigated in 30 patients who had suffered from recurrent episodes. The patients were followed up from 1 to 8.5 years after starting lithium treatment. In the analysis, patients were divided into those who took lithium regularly and those who took it irregularly, the division being based on the lithium plasma levels at the periodic control examinations. The study, which is of the so-called mirror tye, supports the hypothesis that well-conducted lithium maintenance treatment has a favorable morbidity suppressive effect in patients suffering from cycloid psychosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 727892     DOI: 10.1001/archpsyc.1978.01770270078007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  5 in total

1.  [Operationalized diagnosis of schizoaffective and cycloid psychoses].

Authors:  M Zaudig; G Vogl
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

Review 2.  Prevalence and description of psychotic features in bipolar mania.

Authors:  E Dunayevich; P E Keck
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

Review 3.  Lithium intoxication: a coordinated treatment approach.

Authors:  S L Minden; E L Bassuk; S P Nadler
Journal:  J Gen Intern Med       Date:  1993-01       Impact factor: 5.128

4.  Lithium therapy in comorbid temporal lobe epilepsy and cycloid psychosis.

Authors:  Paul Brown; Sridhar Kashiviswanath; Alison Huynh; Naveen Allha; Ken Piaggio; Saddichha Sahoo; Ankur Gupta
Journal:  Oxf Med Case Reports       Date:  2016-12-01

5.  Does a Lack of Awareness of Cycloid Psychosis Hamper Adequate Treatment for Patients Suffering From This Disorder? A Case Report.

Authors:  Armand Hausmann; Julia Dehning; Michel Heil; Laurin Mauracher; Georg Kemmler; Heinz Grunze
Journal:  Front Psychiatry       Date:  2020-11-12       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.